This week, the U.S. Food & Drug Administration (FDA) announced it will not enforce a longstanding policy during the COVID-19 pandemic that requires abortion-inducing drugs to be dispensed during an in-person doctor’s visit. In-person appointments are critical to minimize serious health risks to women both before and after an abortion. But, the Biden Administration chose to appease the powerful abortion lobby instead of protecting women.

This announcement is very likely the pre-cursor to a permanent removal of this important safety regulation and others which will put countless women at risk of health complications, including death.

Chemical abortion is big—and risky—business, especially for Planned Parenthood, where chemical abortion makes up 56% of all abortions performed. This is not by accident. Abortion activists have been quietly building a new business model to target young women through their phones and the internet. When safety regulations are loosened – as the FDA has just done – women suffer. Abortion-inducing drugs are four times more dangerous than surgical abortion, and can cause severe infection, heavy bleeding, loss of fertility and even death.

The change in policy at the FDA is just the latest example of the Biden Administration’s anti-woman agenda, which also includes a push to allow men to take women’s places in athletic competitions and to give them access to private women’s spaces like locker rooms, bathrooms and shelters. Fortunately, the states are pushing back on the Administration’s radical social agenda and are making great strides to protect women.

Family Policy Alliance is part of a national coalition of pro-life, pro-woman organizations that has been working across the nation this year to regulate the chemical abortion industry state by state. We realized last year that the federal FDA safety regulations for chemical abortion drugs were at great risk of repeal if a pro-abortion president were elected.  It’s clear that each state must pass protocols to regulate the dispensing and reporting of abortion-inducing pills if women are to be protected long-term.

Already, six states (Arizona, Arkansas, Indiana, Montana, Oklahoma, and Texas) have acted on our coalition’s model legislation to codify the FDA’s longstanding safety regulations, prevent mail-order abortions, and mandate reporting of chemical abortions.  Half of them – Arkansas, Indiana, and Montana – are awaiting their governor’s signature, and several more states are expected to introduce the legislation soon.

As the Biden Administration runs full steam ahead with an anti-woman and anti-life agenda, FPA and our allies will continue to advocate for the rights and safety of women and children in every state. Your support – both prayerfully and financially – enables us to keep fighting for the family. For that, we are most grateful.

Sincerely,

Amanda Banks
Director, External Relations

 

 

By Brittany Jones, Esq., policy manager for Family Policy Alliance

Earlier this summer it was discovered that the U.S. Food and Drug Administration (FDA) signed a contract with a procurement organization for human fetal tissue, otherwise known as baby body parts, to be used in experiments with mice. The baby body parts are being used to create “humanized mice,” essentially mice with human immune systems.  So not only is the FDA attempting create a part rodent, part human creature in order to do testing, but they are using aborted babies and tax dollars to support defiling human dignity.

As if that weren’t bad enough, this contract encourages the continuation of elective abortions. Across the country over 600,000 abortions happen annually. This contract only increases demand for women to abort their babies.

Further, it inadvertently encourages abortion providers to mislead women about what will happen to their baby once the baby is aborted. The Center for Medical Progress discovered that abortion providers were tricking women into allowing research to be done using their aborted baby’s body parts.

This is why Family Policy Alliance, along with our national ally Susan B. Anthony List and nearly four dozen other prolife leaders, called on Health and Human Services’ head, Secretary Azar, to end the FDA’s contract with the fetal tissue procurement entity. We point out that Advanced Bioscience Resource, the company that the FDA has contracted with, is under federal investigation for profiting from sales of fetal organs. We also question the transparency and the openness of the Department of Health for concealing this contract and other contracts associated with the Department that involve procuring fetal remains.

Importantly, the letter points out that using human baby parts is not medically necessary to do the proposed research. “Contrary to claims, there is no scientific requirement of aborted fetal tissue to construct humanized mice . . . But good scientific alternatives exist to this grisly sourcing . . . There are abundant modern scientific alternatives, making aborted fetal tissue unnecessary.”

If you are interested, you can read the full letter for yourself here.

Hillary Clinton’s claim that women cannot succeed without abortions is false. The claim that we cannot fully understand the human immune system without killing preborn babies and desecrating their remains is false. We hope you will work with us to restore a nation where God is honored and life is cherished.